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ABSTRACT 
 
It is currently difficult to determine the molecular and cellular basis for radioscintigraphic signals 
obtained during macroscopic in vivo imaging. The field is in need of technology that helps bridge 
the macroscopic and microscopic regimes. To solve this problem, we developed a fiducial 
marker (FM) simultaneously compatible with 2-color near-infrared (NIR) fluorescence (700 and 
800 nm), autoradiography (ARG), as well as conventional hematoxylin and eosin (H&E) 
histology. 
Methods: The FM was constructed from an optimized concentration of commercially available 
human serum albumin (HSA), 700 nm and 800 nm NIR fluorophores, 99mTc-pertechnatete, 
DMSO, and glutaraldehyde (GA). Lymphangioleiomyomatosis (LAM) cells co-expressing the 
sodium iodide symporter (NIS) and green fluorescent protein (GFP) were labeled with 700 nm 
fluorophore and 99mTc-pertechnatete, then administered intratracheally into CD-1 mice. After in 
vivo SPECT imaging, and ex vivo SPECT and NIR fluorescence imaging of the lungs, 30 µm 
frozen sections were prepared and processed for 800 nm NIR fluorophore co-staining, ARG, and 
H&E staining on the same slide using the FMs to co-register all data sets.  
Results: Optimized FMs, composed of 100 µM unlabeled HSA, 1 µM NIR fluorescent HSA, 
15% DMSO, and 3% GA in PBS (pH 7.4) were prepared within 15 min, displayed homogeneity 
and stability, and were visible by all imaging modalities, including H&E staining. Using these 
FMs, tissue displaying high signal by SPECT could be dissected and analyzed on the same slide 
and at the microscopic level for 700 nm NIR fluorescence, 800 nm NIR fluorescence, ARG, and 
H&E histopathological staining.  
Conclusion: When multimodal FMs are combined with a new technique for simultaneous same-
slide NIR fluorescence imaging, ARG, and H&E staining, macroscopic in vivo images can now 
be studied unambiguously at the microscopic level. 
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INTRODUCTION 
The development of new clinical radiotracers for single-photon emission computed 
tomography (SPECT) and positron emission tomography (PET) is of critical importance (1,2). 
However, validating that the signal obtained during in vivo radioscintigraphic imaging is 
emanating from the target of interest can be a challenge (3-5). Particularly difficult is the 
validation of signals at the cellular and/or molecular level. 
Clinically, histopathological staining with hematoxylin and eosin (H&E) is the gold 
standard for identification of specific cells and tissues (6), however, ambiguity is common. To 
ensure proper identification, one or more immunomarkers is typically employed, and 
precipitating pigments are used in conjunction with H&E to label cells of interest (3,7). The 
problem with conventional immunohistochemistry, however, is that the H&E image itself is 
masked by the precipitating pigments (8). To solve this problem, our group has previously 
developed a technology to perform two independent wavelengths of near-infrared (NIR) 
fluorescence immunostaining on the same specimen, and the same slide, as conventional H&E 
(Gibbs et al., manuscript in review). Thus, the unadulterated H&E can be used in conjunction 
with immunomarkers to unambiguously identify cells and/or molecules of interest. 
What is needed in the field of nuclear medicine is the ability to correlate 
radioscintigraphic signals measured using macroscopic in vivo imaging techniques with 
validation performed at the single cell level. But, few such techniques exist. For this reason, we 
focused the present study on developing an optimized fiducial marker (FM) that permits 
acquisition and co-registration of H&E, NIR fluorescence, and autoradiography  (ARG) data sets, 
on the same specimen, and on same slide. We hypothesized that such a technology would enable 
unambiguous validation of macroscopic nuclear images at the microscopic level. 
MATERIALS AND METHODS 
Reagents: Cy5.5 NHS ester was purchased from GE Healthcare (Piscataway, NJ), and ZW800-1 
was synthesized as previously reported (9). They were diluted to 10 mM in DMSO and stored at 
-80 ºC under reduced light conditions. Human serum albumin (HSA) and glutaraldehyde (GA) 
were purchased from Sigma (St. Louis, MO) and Electron Microscopy Sciences (Hatfield, PA), 
respectively. 99mTc-pertechnatete was purchased from Cardinal Health (Dublin, OH). The red 
blood cell labeling kit (Ultra Tag® RBC) was purchased from Covidien (Hazelwood, MO). 
Rabbit polyclonal anti-GFP antibody was purchased from Abcam (Cambridge, MA). Magnesium 
chloride and trypsin-versene were purchased from Fisher Scientific (Pittsburgh, PA) and 
Cambrex (Walkersville, MD), respectively. 
 
Preparation of HSA700 and HSA800: All steps were performed under reduced light conditions. 
HSA suspended in PBS pH 7.8 was first purified using gel filtration chromatography (GFC) with 
a Bio-Gel P-6 desalting column (Bio-Rad, Hercules, CA) to remove small molecules that 
interfere with covalent conjugation by NHS esters. Two equivalents of Cy5.5 NHS ester or 
ZW800-1 NHS ester was added to the purified HSA in PBS, pH 7.8 and incubated for 3 h to 
form a stable amide linkage. HSA700 and HSA800 were purified using GFC as above, and the 
labeling ratio was calculated from the ratio of extinction coefficients between the HSA (ε280 nm = 
32,900 M-1cm-1) and the NIR fluorophore (Cy5.5, ε700 nm = 250,000 M-1cm-1; ZW800-1, ε770 nm 
= 249,000 M-1cm-1). The final NIR fluorophore labeling ratios for HSA700 and HSA800 were 
0.95 and 0.96, respectively. The optical spectra of HSA700 and HSA800 were obtained with a 
UV-Visible and fluorescence spectrophotometer (Varian, Santa Clara, CA). Final products were 
stored as 0.2 mM stock solutions in PBS, pH 7.4 at 4 ºC. 
 
Optimization of the Multimodality Fiducial Marker: Unlabeled HSA, HSA700, HSA800, 
99mTc-pertechnatete, DMSO, and GA concentrations were varied systematically, and the 
homogeneity and stability of conjugation to an amine-coated Superfrost® Plus (VWR, Bridgeport, 
NJ) microscope slide was measured. Reagents were vortexed together gently at room 
temperature (RT) and 0.2 µL of the solution spotted by hand onto the glass slide. The FM was 
then incubated for 15 min at RT, washed with distilled water, and dried for 15 min at RT. The 
glass slide was exposed to a phosphorimaging screen overnight at -20 °C and the screen read 
using a Typhoon™ 9400 system (GE Healthcare). The pixel size and depth were set to 25 µm 
and 16-bits, respectively. Phosphorimaging screen was erased for a minimum of 2 h before the 
next experiment and confirmed to be back to baseline.  
 
Multichannel Fluorescence Microscope: HSA700 and HSA800 were imaged on a Nikon TE 
300 microscope system equipped with mercury and xenon excitation sources (Chiu Technical 
Corporation, Kings Park, NY) and an Orca-ER 12-bit camera (Hamamatsu, Bridgewater, NJ). To 
obtain fluorescence images of HSA700, the xenon light source was passed through a 650/45-nm 
BP excitation filter and a 700/35-nm BP emission filter (Chroma Technology, Brattleboro, VT). 
To obtain fluorescence images of HSA800, the xenon light source was passed through a 750/50-
nm BP excitation filter and an 810/40-nm BP emission filter (Chroma). Slides were then H&E 
stained using a standard clinical protocol. The signal intensity, homogeneity, and shape of all 
obtained fluorescence images were compared before and after H&E staining. 
 
Labeling and Imaging of LAM cells: LAM 621-327 cells (10) were cultured in a 50/50 mixture 
of DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with epidermal growth factor (EGF, 10 
ng/ml; Sigma-Aldrich, St. Louis, MO), 200-nM hydrocortisone (Sigma-Aldrich), 25-µg/ml 
insulin (Sigma-Aldrich), 50-nM sodium selenite (Sigma-Aldrich), 10-µg/ml transferrin (Sigma-
Aldrich), 1.6-µM ferrous sulfate (Sigma-Aldrich), and 15% fetal bovine serum (Gemini). LAM 
cells were grown at approximately 70% confluence on a 10-cm diameter tissue culture plate and 
washed once with PBS containing 1-mM MgCl2. LAM cells were labeled with 2-µM Cy5.5 NHS 
ester in 10 mL PBS/MgCl2 for 30 min at 37°C, washed 3 times, and 10% of the components of 
the Ultra Tag RBC labeling kit was added. LAM cells were mixed by gently inverting the 
components of the RBC kit for 10 min at 37 °C then 37 MBq (1 mCi) of 99mTc-pertechnetate was 
added to the plate. After gentle rocking for 2 h at 37 °C, cells were washed once with buffer and 
trypsinized by adding 2 mL trypsin-versene (Sigma-Aldrich). LAM cells labeled with Cy5.5 and 
99mTc were then washed 3 times by centrifuging at 2000 rpm for 5 min. The supernatant was 
discarded carefully, so as not to disturb the cell pellet. The LAM cells were resuspended in 200-
µL PBS/MgCl2 and loaded on the microscope glass slide for ARG scanning. ARG was 
performed using the same parameters as described above. The signal of GFP was then imaged 
using a fluorescence microscope equipped with a 480/40-nm BP excitation filter and a 535/50-
nm BP emission filter.  
 
Immunofluorescence staining: ZW800-1 conjugated donkey (Dk) anti-rabbit (Rb) secondary 
antibody was prepared as follows: 400 µL of Dk antibody (stock concentration = 1.2 mg/mL) 
was buffer exchanged with PBS using spin columns (Vivaspin 500, 10 kDa MWCO, GE 
Healthcare) to eliminate any sodium azide that might be present in the stock solution. The buffer 
exchange was performed using centrifugation at 8000 rpm 5 times, 3 min each. The antibody 
solution was adjusted to pH 8 and 5-25 equivalents of ZW800-1 NHS ester was added. After 3-h 
reaction at RT, the NIR-antibody conjugate was purified using GFC as described above. Purified 
fractions were collected and concentrated to 50 µL volume by centrifugation at 10,000 rpm for 3 
min. The labeling ratio, calculated from the ratio of extinction coefficients for the antibody (ε280 
nm = 150,000 M-1cm-1) and ZW800-1 (ε770 nm = 249,000 M-1cm-1), was 1.5. PBS containing 2.5% 
goat serum was added to the slide and incubated for 1 h at RT to block nonspecific protein 
binding sites. Then, the Rb polyclonal anti-GFP antibody (1:100 dilution in PBS + 0.1% bovine 
serum albumin + 0.1% Tween 20) was added and incubated overnight at RT. After washing 3 
times with PBS containing 0.5% Tween 20 (PBS/T), 5-µM ZW800-1 conjugated secondary 
antibody was added and incubated for 2 h at RT. After incubation, the LAM cells were washed 
with PBS/T 3 times, 5 min each time. LAM cells were then fixed in 2% paraformaldehyde in 
PBS for 15 min at RT, and then stained with H&E. After H&E staining, color imaging and 800 
nm anti-GFP immunofluorescence imaging were performed. 
 
In Vivo and Ex Vivo Imaging: Animals used in this study were housed in an Association for 
Assessment and Accreditation of Laboratory Animal Care (AAALAC)-certified facility, staffed 
by full-time veterinarians. Animal studies were performed under the supervision of Beth Israel 
Deaconess Medical Center’s Institutional Animal Care and Use Committee (IACUC) in 
accordance with approved institutional protocol #155-2008. CD-1 mice of either sex, 8 to 10 
weeks in age were purchased from Charles River Laboratories (Wilmington, MA). Mice were 
anesthetized with 100-mg/kg ketamine and 10-mg/kg xylazine (Webster Veterinary, Fort Devens, 
MA) intraperitoneally. 18G gavage tubing (Fine Science Tool, Foster, CA) was placed in the 
trachea and 10 x 106 LAM cells labeled with Cy5.5 and 99mTc in 150-µL PBS/MgCl2 
administered intratracheally. After 15 min, the mice underwent euthanasia, and a thoracotomy 
procedure was performed to enucleate the lung tissues.  
SPECT and CT images were acquired using a NanoSPECT/CT® scanner (Bioscan, Inc., 
Washington. D.C., USA) equipped has 4 NaI(Tl) detectors. For SPECT imaging, 9-pinhole 
apertures with a diameter of 1.4 mm were used on each detector. The energy window was set at 
140 keV ± 20%. SPECT imaging was performed at 24 projections/rotation and 300 s/projection. 
The projected data were reconstructed using HiSPECT® software (Scivis, Göttingen, Germany) 
and a dedicated ordered-subsets expectation-maximization (OSEM) algorithm employing 
multiplexed Multi-Pinhole SPECT technology. Voxel size and Gaussian filter size (full width at 
half maximum; FWHM) were set at 0.3 mm and 1.9 mm, respectively. The iterative update 
number (subset × iteration) was 27. A CT scan was performed at 45 kVp, 177 µA, 240 
projections/rotation using a CMOS detector with a 96-µm pixel size. Projected data were 
reconstructed by setting the voxel size to 100 µm.  
After in vivo SPECT/CT imaging, the lung tissue was excised and imaged ex vivo using 
the same protocol. The 700-nm NIR fluorescence and color images were then imaged with the 
FLARE™ real-time intraoperative imaging system, as described in detail previously (11,12). 
Extracted lung tissues were placed in 2% paraformaldehyde in PBS for 30 min before mounting 
on the Tissue-Tek OCT (Sakura Finetek, Torrance, CA). The sample was frozen in liquid 
nitrogen and cryosectioned into a 30-µm thick section for fluorescence imaging, ARG, and H&E 
staining. Three FMs were placed around the tissue. After ARG scanning and H&E staining, anti-
GFP antibody staining was performed using the optimized protocol as described above. The dual 
channel NIR fluorescence and color images were obtained using a Nikon 55i fluorescence 
microscope equipped with an encoded motorized stage (Prior Scientific). To obtain the 700-nm 
fluorescence image, the xenon lamp was passed through a 650/45-nm BP excitation filter, a 680-
nm LP dichroic, and a 710/50-nm BP emission filter. For 800-nm fluorescence imaging, the 
xenon lamp was passed through a 750/50-nm BP excitation filter, 810-nm LP dichroic, and an 
824/47-nm BP emission filter. The obtained dual NIR fluorescence and ARG images were then 
merged with the H&E histology image based on the pre-positioned 3 FMs. 
RESULTS 
Optimization of the Fiducial Marker: The chemical structures and optical spectra of HSA700 
and HSA800 are shown in Figure 1. Since the half-life of 99mTc is relatively short (T1/2 = 6 h) and 
a stable chemical reaction is required, we used a simple and facile cross-linking reaction to 
conjugate albumin to the glass slide while simultaneously trapping 99mTc pertechnetate in the 
protein mesh (27). The type of slide most commonly used in clinical histopathology laboratories 
is the “plus” slide. The primary amines conjugated to the surface of the plus slide helps tissue 
adhere and also serves as the matrix for FM conjugation. 
Preparing FMs that were perfectly homogeneous, however, proved to be a challenge. 
99mTc-pertechnetate (0.37 KBq/µL; 0.01 µCi/µL), unlabeled HSA (100 µM), HSA700 (1 µM), 
and HSA800 (1 µM) were fixed in PBS, pH 7.4, at several different concentrations of GA (1%, 
3%, and 5%) and with different concentrations of DMSO (0%, 5%, 10%, and 15%) for 15 min at 
RT. The NIR fluorescence signal of HSA700 and HSA800 were imaged before and after H&E 
staining to ensure that the FM was stable. In all conditions tested, the signal intensity and shape 
of FMs were not altered significantly by H&E staining, and the FM was visible by brightfield 
microscopy (Figure 2). However, homogeneity of the FMs was improved by increasing the 
concentrations of GA and DMSO. Optimized conditions for FM production were found to be 
100 µM unlabeled HSA, 1 µM HSA700, 1 µM HSA800, 0.01 µCi/µL (0.37 KBq/µL) 99mTc 
pertechnetate, 3% GA, and 15% DMSO in PBS (pH 7.4) for 15 min at RT.  
 
Cell Labeling and Imaging: To create single cells that were NIR fluorescent at 700 nm and 800 
nm, as well as radioactive, LAM cells stably co-expressing NIS and GFP were incubated with 
99mTc-pertechnetate and 700 nm Cy5.5 NHS (Figure 1). After fixation, GFP was detected using 
an unlabeled primary antibody and an 800 nm NIR fluorescent secondary antibody (Figure 3B). 
Although expression of NIS alone is sufficient to accumulate 99mTc-pertechnetate into a cell 
(13,14), we found that incubation with Sn2+, which diffuses across the cell membrane, 
accumulates intracellularly, and reduces Tc7+, helped to retain the radioisotope. 
 The inherent differences in sensitivity, specificity, and resolution among microscopic 
NIR fluorescence imaging, ARG, and H&E staining are shown in Figure 3C. In particular, 
currently available phosphorimaging cassettes are not designed for high-energy isotopes, 
resulting in significant blurring of what would otherwise be single cell resolution of the ARG 
signal.  
 
Microscopic Analysis of Macroscopic Radioscintigraphic Images: 700 nm NIR fluorescent 
and radioactive LAM cells were administered intratracheally into CD-1 mice (Figure 4A) and in 
vivo SPECT/CT imaging was performed (Figure 4B). After surgical removal of the lung, 
SPECT/CT, color, and 700-nm fluorescence images were obtained (Figure 4B) and a portion of 
lung tissue having both optical and nuclear signal was excised and processed as described in 
Materials and Methods. As shown in Figure 4C, it was possible to analyze 2 independent 
channels (700 nm and 800 nm) of NIR fluorescence, as well as ARG, on the same specimen, on 
the same slide, with all data sets able to be co-registered using the FMs. Both NIR fluorescent 
and H&S optical imaging could be performed with single cell resolution (Figure 4D). As might 
be expected based on the experimental protocol, LAM cells were found to be distributed peri-
bronchially (Figure 4D). 
DISCUSSION 
This study addressed a fundamental problem in the field of nuclear medicine, the 
validation of macroscopic radioscintigraphic signals at the microscopic level. Having already 
optimized two channels of NIR fluorescence microscopy with H&E staining on the same slide 
(Gibbs et al., manuscript in review), we assumed that adding the ARG data set would be 
straightforward. On the contrary, co-registration of data sets between optical and nuclear imaging 
was found to be a major issue because ARG lacks identifiable landmarks and was acquired the 
night before the optical images. Even if a dual-functional diagnostic agent (i.e., SPECT/NIR 
fluorescent probe) is utilized, a similar problem has been reported (15).  
To circumvent this issue, we describe a simple, inexpensive, FM that can be applied to a 
standard “plus” slide and permits rotation, translation, and morphing of data sets as needed 
among brightfield microscopy, NIR fluorescence immunomicroscopy, and ARG. This FM can be 
created with commercially available reagents in only 15 min, which is an important point when 
considering the short half-life of many SPECT and PET radiotracers. 
The biological example we show in this study, namely the tracking of LAM cells after 
administration into the airspaces of the lung, actually has important implications. Our group 
recently described a new animal model of LAM and the related disease tuberous sclerosis 
complex (TSC) that recapitulates the homing of LAM/TSC cells to virtually every lymph node 
basin in the body (10). However, it is extremely difficult to study the mechanism of cellular 
translocation and lymph node homing because the process involves single cells. Armed with the 
technology described in this paper, it should now be possible to track cells using in vivo imaging 
methods and to analyze the source of measured signals at the microscopic level. This same 
strategy could be used to study similar processes, such as the early steps of cancer metastasis. 
Nevertheless, our study also has limitations. The resolution of conventional ARG using 
phosphorimaging is inadequate. Currently available phosphorimaging plates are not designed for 
high-energy gamma radioisotopes, and significant blurring of resolution occurs (see, for example, 
Figure 4C). Estimates of full-width at half-maximum (FWHM) resolution for 99mTc and 18F are 
350 µm and 460 µm, respectively (16). Fortunately, the development of high-resolution ARG 
systems is an active area of investigation (17-19) and it is hoped that such systems will become 
commercially available in the near future. 
CONCLUSION 
We developed a specialized FM and processing techniques that permitted same-slide 
ARG, 700-nm and 800-nm NIR fluorescence, and H&E histopathological analysis at the single 
cell level. FM marker preparation took only 15 min using readily available reagents. Using this 
technology, macroscopic nuclear images can be validated at the microscopic level. 
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FIGURE LEGENDS    
 
 
Figure 1 – Chemical structure and optical spectra of fiducial markers and cell labeling 
reagents: HSA700 and HSA800 for fiducial markers were prepared by conjugating Cy5.5 and 
ZW800-1, respectively to purified human serum albumin (HSA). Cell labeling was performed 
using Cy5.5 NHS ester (700 nm fluorophore) and ZW800-1-conjugated donkey anti-rabbit (Dk α 
Rb) antibody. Shown are chemical structures (left) and optical spectra (right). 
 
 
 
 
Figure 2 – Optimization of fiducial markers: Unlabeled HSA (100 µM), HSA700 (1 µM), 
HSA800 (1 µM), and 99mTc-pertechnetate (0.01 µCi/µL; 0.37 KBq/µL) in PBS, pH 7.4 were 
fixed while the concentrations of GA and DMSO were systematically varied as shown. NIR 
fluorescence signal intensity was measured before (top) and after (bottom) H&E staining. ARG 
was measured before H&E staining only. All NIR fluorescence images have identical exposure 
times and normalizations. Data are representative of n = 3 independent experiments. 
  
Figure 3 – Multimodality labeling of single cells:  
A.  Summary of the various NIR fluorescent and radioactive molecules used to label LAM 
cells. Cy5.5 NHS ester (700-nm NIR) was conjugated to the cell membrane. ZW800-1 
(800-nm NIR) conjugated secondary antibody was used for immunofluorescence staining 
of GFP. 99mTc-pertachnetate was accumulated via NIS, while stannous ion (Sn2+) was 
used to improve retention of the radioisotope in the cell. 
B. Immunofluorescence staining of GFP. Rabbit polyclonal anti-GFP antibody and ZW800-
1 conjugated donkey anti-rabbit secondary antibody staining of LAM cells expressing 
GFP. The 500-nm fluorescence signal for GFP was imaged before H&E staining, while 
800-nm fluorescence and color microscopy was performed after H&E staining.  
C. Multimodality microscopy of LAM cells. Shown are the 700-nm fluorescence image, 
autoradiography (ARG), and H&E color image for a 4 mm diameter spot of LAM cells 
on a glass slide. Note single cell resolution by NIR fluorescence and H&E.  
 
 
 
Figure 4 – In vivo and ex vivo multifunctional imaging:  
A. Schematic representation of the in vivo mouse model. Labeled LAM cells (see Figure 3A) 
were administered intratracheally into CD-1 mice using gavage tubing.  
B.  In vivo maximal intensity projection (MIP) SPECT/CT image (left) and ex vivo color, 
700-nm fluorescence, color-NIR merge (700 nm signal is pseudo-colored in red) and MIP 
SPECT/CT images (right) of the excised lung. Images shown are representative of n = 3 
independent experiments. The dashed white rectangle delineates the excised tissue 
sample studied in Figure 4C. 
 
 
Figure 4 – In vivo and ex vivo multifunctional imaging (Continued):  
C.  Same-slide 700 nm NIR fluorescence (cell membrane staining), 800 nm NIR 
fluorescence (anti-GFP staining), ARG, and H&E staining of LAM cells in the lung 
tissue of a CD-1 mouse. 2 mm diameter multimodal FMs visible in each image were used 
to co-register the data sets.  
D. Same as (C) but at higher magnification, with the 700 nm NIR fluorescent signal pseudo-
colored in red, the 800 nm NIR fluorescent signal pseudo-colored in green, and the ARG 
signal superimposed on the H&E image. 
